FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2005346853> ?p ?o ?g. }

• W2005346853 endingPage "756" @default.
• W2005346853 startingPage "755" @default.
• W2005346853 abstract "The mechanisms of local anesthetic cytotoxicity remain unclear. Inhibition of voltage-gated sodium channels, cytoplasmic calcium dysregulation, membrane solubilization, and apoptosis have all been suggested (1,2). Two studies, published in an abstract form, have suggested that lidocaine can induce apoptosis in cultured neurons (3,4). Our objective was to compare the apoptotic properties of two local anesthetics, lidocaine and ropivacaine, on cell cultures. Methods A human lymphoma T-cell line Jurkat culture was maintained in exponential growth in RPMI 1640 medium (Roswell Park Memorial Institute; Life Technologies Ltd, Paisley, Scotland) supplemented with 10% (vol/vol) heat inactivated (30 min, 56°C) fetal bovine serum (Life Technologies Ltd), 100 μg/mL of streptomycin, 100 IU of penicillin, and 2 mM of l-glutamine (Life Technologies Ltd). Cells were cultured in fully humidified atmosphere of 5% CO2/95% air at 37°C. Annexin V, fluorescein isothiocyanate (FITC), and propidium iodide (PI) were purchased from Zymed Laboratories (ApoDETECT™ Annexin V-FITC kit; San Francisco, CA). Lidocaine chlorydrate and ropivacaine chlorydrate were both purchased from Astra Zeneca Laboratories (Rueil Malmaison, France). During the early stages of apoptosis, phosphatidylserine (PS) is translocated to the outer layer of the plasma membrane. This event can be detected by using a sensitive method to detect PS exposure (5). This phenomenon also occurs during cell necrosis; however, the cell becomes leaky and loses its integrity. Therefore, it is required to assess membrane integrity together with PS translocation. Based on its affinity for PS, Annexin V can be used as a sensitive probe for cell surface exposure of PS. To use Annexin V as a probe for apoptotic cells, the protein is labeled with FITC. In this form, the protein can be used directly for quantification of apoptotic cells. The measurement of Annexin V binding when performed simultaneously with a dye exclusion test, such as PI, can be used to effectively discriminate between apoptotic and necrotic cells (5). After more than 95% cell viability was confirmed by trypan blue staining, suspensions of 4 × 105 cells were incubated in a 2-mL medium at 37°C with either lidocaine 6 mg/mL or ropivacaine 1 mg/mL for 1–6 h. Other samples were incubated in the 2-mL medium alone as a control. After incubation, cells were centrifuged for 1 min at 3000 rpm, then washed in ice-cold phosphate-buffered solution, with a pH value of 7.4, and again centrifuged at 3000 rpm. Cells were resuspended in 190 μL of binding buffer (10 mM of HEPES/NaOH, pH value of 7.4, 140 mM of NaCl, and 2.5 mM of CaCl2), and 10 μL of Annexin V-FITC was added. Cells were washed in binding buffer and centrifuged for 1 min at 3000 rpm and then resuspended in 190 μL of binding buffer, and 10 μL of 20-μg/mL PI stock solution was added. Apoptotic cells can be recognized and distinguished from necrotic cells using flow cytometry (FACScan; Becton Dickinson Systems, San Jose, CA) after double staining by Annexin V-FITC and PI (5). Apoptotic cells exclude all those dyes that are in use for cell viability assays, such as PI, whereas necrotic cells do not. In cells with a damaged cell membrane, PI induces a red fluorescence of the DNA, whereas it is excluded by cells with a preserved cytoplasm in the membrane. Hence, during the initial phase of apoptosis, the cells are still able to exclude PI and therefore do not show any red fluorescence signal, which is similar to that of living cells. PS is exposed on the external surface of apoptotic cells but not viable cells and thus are positive for Annexin V-FITC binding, which is detected by a green fluorescence. This method allows one to distinguish apoptotic cells (FITC+/PI−, green fluorescence), necrotic cells (FITC+/PI+, red and green fluorescence), and viable cells (FITC−/PI−, no fluorescence). All data were expressed as a mean ± sd percentage of apoptotic cells in each sample (Fig. 1). Statistical analyses for apoptotic cells (FITC+/PI−) were performed using the Statview software (SAS Institute, Cary, NC) with an analysis of variance for repeated measures. Significant differences (P < 0.05) were identified using Bonferroni adjusted comparison test.Figure 1: Increasing mean percentage of apoptotic Jurkat T cells after different times of incubation with 6 mg/mL of lidocaine and 1 mg/mL of ropivacaine. Error bars indicate sd. *P < 0.05 versus zero hours. †P < 0.05 versus ropivacaine and control.Results In the control samples, a mean baseline of 4.1% of apoptotic cells was initially observed, and no increase of this percentage was observed during the time of the study. In the samples incubated with 1 mg/mL of ropivacaine, the mean baseline percentage of apoptotic cells was 4.1%, and this number increased to 6.7% after 6 h of incubation, which corresponds to a 165% increase, although it was not statistically significant. For the samples incubated with 6 mg/mL of lidocaine, a statistically significant (P < 0.05) increase of apoptotic cells appeared after 4 h of incubation and reached 392% after 6 h of incubation (from 4.2% to 16.5%) (Fig. 1). Discussion The findings of our study suggest that, with the concentrations tested, lidocaine, but not ropivacaine, can induce apoptosis on T-cell line cultures in a time-dependent manner in vitro. Cell toxicity induced by local anesthetics has been widely studied in animal and in vitro models, although its mechanism remains unclear (2). It seems that local anesthetics lead to a perturbation of energetic cell metabolism (1). Little is known about the induction of apoptosis by local anesthetics on cell cultures. Only one study has suggested the possible induction of apoptosis by cocaine on embryonic brain cells (6). In a recent study, published in an abstract form, the authors suggested that small doses of lidocaine (2.5 mg/mL) cause neuronal injury and apoptosis on neuronal cell lines derived from rat dorsal root ganglion (4). There is no information in the literature about the induction of apoptosis in cell cultures by ropivacaine. The method of detection of apoptosis by dual staining with Annexin V-FITC was chosen, although there are more conventional methodologies such as the TUNEL (terminal deoxynucleotidyl transferase technique) method, and this quite elegant method has been widely used in recent studies devoted to the induction of apoptosis (7–9). Our objective was to determine whether lidocaine and ropivacaine could induce apoptosis on cell cultures. The induction of apoptosis might be one explanation of cell toxicity caused by local anesthetics, especially with lidocaine. As a preliminary study, only one concentration for each local anesthetic was chosen, and the model chosen was a Jurkat T-cell line because this line can be cultivated with routine techniques, as compared with neurons. These results are encouraging, and further dose-response studies tested on a neuronal model and providing indications of the molecular mechanisms underlying these actions are required to determine the clinical relevance of these findings." @default.
• W2005346853 created "2016-06-24" @default.
• W2005346853 creator A5001923755 @default.
• W2005346853 creator A5010065275 @default.
• W2005346853 creator A5014519093 @default.
• W2005346853 creator A5034176985 @default.
• W2005346853 creator A5041618403 @default.
• W2005346853 creator A5048844055 @default.
• W2005346853 creator A5081297649 @default.
• W2005346853 date "2003-03-01" @default.
• W2005346853 modified "2023-10-03" @default.
• W2005346853 title "The Induction of Apoptosis by Local Anesthetics: A Comparison Between Lidocaine and Ropivacaine" @default.
• W2005346853 cites W1963505233 @default.
• W2005346853 cites W1964951216 @default.
• W2005346853 cites W1966199308 @default.
• W2005346853 cites W2058700471 @default.
• W2005346853 cites W2078532650 @default.
• W2005346853 cites W2079111643 @default.
• W2005346853 cites W2126396760 @default.
• W2005346853 cites W2128715562 @default.
• W2005346853 doi "https://doi.org/10.1213/01.ane.0000047201.85815.9d" @default.
• W2005346853 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12598258" @default.
• W2005346853 hasPublicationYear "2003" @default.
• W2005346853 type Work @default.
• W2005346853 sameAs 2005346853 @default.
• W2005346853 citedByCount "49" @default.
• W2005346853 countsByYear W20053468532012 @default.
• W2005346853 countsByYear W20053468532013 @default.
• W2005346853 countsByYear W20053468532014 @default.
• W2005346853 countsByYear W20053468532015 @default.
• W2005346853 countsByYear W20053468532016 @default.
• W2005346853 countsByYear W20053468532017 @default.
• W2005346853 countsByYear W20053468532018 @default.
• W2005346853 countsByYear W20053468532019 @default.
• W2005346853 countsByYear W20053468532020 @default.
• W2005346853 countsByYear W20053468532021 @default.
• W2005346853 countsByYear W20053468532023 @default.
• W2005346853 crossrefType "journal-article" @default.
• W2005346853 hasAuthorship W2005346853A5001923755 @default.
• W2005346853 hasAuthorship W2005346853A5010065275 @default.
• W2005346853 hasAuthorship W2005346853A5014519093 @default.
• W2005346853 hasAuthorship W2005346853A5034176985 @default.
• W2005346853 hasAuthorship W2005346853A5041618403 @default.
• W2005346853 hasAuthorship W2005346853A5048844055 @default.
• W2005346853 hasAuthorship W2005346853A5081297649 @default.
• W2005346853 hasConcept C2778994108 @default.
• W2005346853 hasConcept C2780149897 @default.
• W2005346853 hasConcept C2780269707 @default.
• W2005346853 hasConcept C42219234 @default.
• W2005346853 hasConcept C71924100 @default.
• W2005346853 hasConceptScore W2005346853C2778994108 @default.
• W2005346853 hasConceptScore W2005346853C2780149897 @default.
• W2005346853 hasConceptScore W2005346853C2780269707 @default.
• W2005346853 hasConceptScore W2005346853C42219234 @default.
• W2005346853 hasConceptScore W2005346853C71924100 @default.
• W2005346853 hasLocation W20053468531 @default.
• W2005346853 hasOpenAccess W2005346853 @default.
• W2005346853 hasPrimaryLocation W20053468531 @default.
• W2005346853 hasRelatedWork W1987256986 @default.
• W2005346853 hasRelatedWork W2004825434 @default.
• W2005346853 hasRelatedWork W2029737826 @default.
• W2005346853 hasRelatedWork W2030367869 @default.
• W2005346853 hasRelatedWork W2054253632 @default.
• W2005346853 hasRelatedWork W2329355530 @default.
• W2005346853 hasRelatedWork W2358587172 @default.
• W2005346853 hasRelatedWork W2381057154 @default.
• W2005346853 hasRelatedWork W2388539920 @default.
• W2005346853 hasRelatedWork W2947539016 @default.
• W2005346853 isParatext "false" @default.
• W2005346853 isRetracted "false" @default.
• W2005346853 magId "2005346853" @default.
• W2005346853 workType "article" @default.